Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COPART INCCPRT · Entity 3146 | EVP Strategic Initiatives | December 20, 2016 | December 22, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COPART INC
Report date December 20, 2016 · Filed December 22, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,181 |
Reported balance
After 2016-12-20 transaction · row 1
1 source rowRow 1 · 2016-12-20 · Sale · Disposed 3,000 · Balance 3,181 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Forterra, Inc.
Report date March 18, 2022 · Filed March 18, 2022
Section 16 reporting ended · disclosed 2022-03-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-03-18 transaction · row 1
1 source rowRow 1 · 2022-03-18 · Disposition to issuer · Disposed 268,920 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of February 19, 2021 (the "Merger Agreement"), by and among Forterra, Inc., a Delaware corporation, (the "Company", Quikrete Holdings, Inc., a Delaware corporation ("Parent"), and Jordan Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company continuing as the surviving corporation in the Merger and a wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.001 per share, of the Company ("Common Stock") was canceled and converted automatically into the right to receive $24.00 per share in cash, without interest and less any applicable tax withholdings. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.92 · Expires 2027-08-07 | Direct | 0 |
Reported balance
After 2022-03-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-03-18 · Disposition to issuer · Disposed 34,384 · Balance 0 F2: Pursuant to the Merger Agreement, each option to purchase shares of Common Stock immediately prior to the effective time of the Merger fully vested and converted into the right to receive, without interest and less any applicable tax withholdings, $24.00 in cash. F3: Vested in equal installments on 8/7/2018, 8/7/2019, and 8/7/2020. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.16 · Expires 2027-12-12 | Direct | 0 |
Reported balance
After 2022-03-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-03-18 · Disposition to issuer · Disposed 32,967 · Balance 0 F2: Pursuant to the Merger Agreement, each option to purchase shares of Common Stock immediately prior to the effective time of the Merger fully vested and converted into the right to receive, without interest and less any applicable tax withholdings, $24.00 in cash. F4: Vested in equal installments on 12/12/2018, 12/12/2019, and 12/12/2020. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.29 · Expires 2028-03-01 | Direct | 0 |
Reported balance
After 2022-03-18 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-03-18 · Disposition to issuer · Disposed 55,891 · Balance 0 F2: Pursuant to the Merger Agreement, each option to purchase shares of Common Stock immediately prior to the effective time of the Merger fully vested and converted into the right to receive, without interest and less any applicable tax withholdings, $24.00 in cash. F5: Vested in equal installments on 3/1/2019, 3/1/2020, and 3/1/2021. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.24 · Expires 2029-03-14 | Direct | 0 |
Reported balance
After 2022-03-18 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-03-18 · Disposition to issuer · Disposed 40,618 · Balance 0 F2: Pursuant to the Merger Agreement, each option to purchase shares of Common Stock immediately prior to the effective time of the Merger fully vested and converted into the right to receive, without interest and less any applicable tax withholdings, $24.00 in cash. F6: Vested in equal installments on 3/14/2020, 3/14/2021, and 3/14/2022. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-03-18 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-03-18 · Disposition to issuer · Disposed 64,656 · Balance 0 F7: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F8: Pursuant to the Merger Agreement, each restricted stock unit outstanding immediately prior to the consummation of the Merger was canceled and converted into the right to receive, without interest and less any applicable tax withholdings, $24.00 in cash. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of February 19, 2021 (the "Merger Agreement"), by and among Forterra, Inc., a Delaware corporation, (the "Company", Quikrete Holdings, Inc., a Delaware corporation ("Parent"), and Jordan Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company continuing as the surviving corporation in the Merger and a wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.001 per share, of the Company ("Common Stock") was canceled and converted automatically into the right to receive $24.00 per share in cash, without interest and less any applicable tax withholdings.
F2: Pursuant to the Merger Agreement, each option to purchase shares of Common Stock immediately prior to the effective time of the Merger fully vested and converted into the right to receive, without interest and less any applicable tax withholdings, $24.00 in cash.
F3: Vested in equal installments on 8/7/2018, 8/7/2019, and 8/7/2020.
F4: Vested in equal installments on 12/12/2018, 12/12/2019, and 12/12/2020.
F5: Vested in equal installments on 3/1/2019, 3/1/2020, and 3/1/2021.
F6: Vested in equal installments on 3/14/2020, 3/14/2021, and 3/14/2022.
F7: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
F8: Pursuant to the Merger Agreement, each restricted stock unit outstanding immediately prior to the consummation of the Merger was canceled and converted into the right to receive, without interest and less any applicable tax withholdings, $24.00 in cash.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2018 Filed Mar 5, 2018 18:07 UTC | Forterra, Inc. FRTA · Entity 128941 | GrantStock Option (Right to Buy) · Derivative | 109,091 | $0.00 Strike: $7.29 | $0.00 |
DisclosureSEC source: 0001678463-18-000015 · wf-form4_152029123137893.xml · derivative · entry 1 BHATIA VIKRANT · CIK 0001628240 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,091 Underlying: Common Stock · 109,091 shares Expires 2028-03-01 F2 · price: Granted as compensation for services. F1 · derivative.exercise_date: Stock Option vests in three equal installments on the first, second and third anniversaries of the grant date. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 18:21 UTC | Forterra, Inc. FRTA · Entity 128941 | GrantStock Option (Right to Buy) · Derivative | 32,967 | $0.00 Strike: $9.16 | $0.00 |
DisclosureSEC source: 0001678463-17-000126 · wf-form4_151329367345351.xml · derivative · entry 2 BHATIA VIKRANT · CIK 0001628240 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,351 Underlying: Common Stock · 32,967 shares Expires 2027-12-12 F1 · price: Granted as compensation for services. F2 · derivative.exercise_date: Stock Option vests in three equal installments on the first, second and third anniversaries of the grant date. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 18:21 UTC | Forterra, Inc. FRTA · Entity 128941 | GrantCommon Stock | 8,734 | $0.00 | $0.00 |
DisclosureSEC source: 0001678463-17-000126 · wf-form4_151329367345351.xml · nonDerivative · entry 1 BHATIA VIKRANT · CIK 0001628240 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,703 F1 · price: Granted as compensation for services. Read SEC document |
| December 12, 2017 Filed May 30, 2018 16:43 UTC Amendment | Forterra, Inc. FRTA · Entity 128941 | GrantRestricted Stock Unit · Derivative | 8,734 | $0.00 | $0.00 |
DisclosureSEC source: 0001678463-18-000057 · wf-form4a_152771296645798.xml · derivative · entry 2 BHATIA VIKRANT · CIK 0001628240 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,734 Underlying: Common Stock · 8,734 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Amendment filed to move restricted stock units from Table I to Table II. F2 · price: Granted as compensation for services. F4 · derivative.exercise_date: Restricted stock units vest in three equal installments on the first, second and third anniversaries of the grant date. F4 · derivative.expiration_date: Restricted stock units vest in three equal installments on the first, second and third anniversaries of the grant date. Read SEC document |
| December 12, 2017 Filed May 30, 2018 16:43 UTC Amendment | Forterra, Inc. FRTA · Entity 128941 | GrantStock Option (Right to Buy) · Derivative | 32,967 | $0.00 Strike: $9.16 | $0.00 |
DisclosureSEC source: 0001678463-18-000057 · wf-form4a_152771296645798.xml · derivative · entry 1 BHATIA VIKRANT · CIK 0001628240 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,967 Underlying: Common Stock · 32,967 shares Expires 2027-12-12 F2 · price: Granted as compensation for services. F1 · derivative.exercise_date: Stock options vest in three equal installments on the first, second and third anniversaries of the grant date. Amendment filed to correct total in column 9. F1 · balance_after: Stock options vest in three equal installments on the first, second and third anniversaries of the grant date. Amendment filed to correct total in column 9. Read SEC document |
| September 11, 2017 Filed Sep 11, 2017 19:52 UTC | Forterra, Inc. FRTA · Entity 128941 | PurchaseCommon Stock | 25,000 | $4.07 | $101,750.00 |
DisclosureSEC source: 0001678463-17-000080 · wf-form4_150517396341565.xml · nonDerivative · entry 1 BHATIA VIKRANT · CIK 0001628240 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,969 F1 · price: The reported transaction was executed in multiple trades at prices ranging from $4.02 to $4.09. The price reported in Column 4 reflects the weighted average purchase price, rounded to the nearest hundredth. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares acquired at each separate price within the range noted. Read SEC document |
| August 07, 2017 Filed Aug 9, 2017 19:34 UTC | Forterra, Inc. FRTA · Entity 128941 | GrantStock Option (Right to Buy) · Derivative | 34,384 | $0.00 Strike: $8.92 | $0.00 |
DisclosureSEC source: 0001678463-17-000057 · wf-form4_150232164004474.xml · derivative · entry 2 BHATIA VIKRANT · CIK 0001628240 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,384 Underlying: Common Stock · 34,384 shares Expires 2027-08-07 F1 · price: Granted as compensation for services. F2 · derivative.exercise_date: Stock Option vests in three equal installments on the first, second and third anniversaries of the grant date. Read SEC document |
| August 07, 2017 Filed Aug 9, 2017 19:34 UTC | Forterra, Inc. FRTA · Entity 128941 | GrantCommon Stock | 8,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001678463-17-000057 · wf-form4_150232164004474.xml · nonDerivative · entry 1 BHATIA VIKRANT · CIK 0001628240 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,969 F1 · price: Granted as compensation for services. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 22:28 UTC | COPART INC CPRT · Entity 3146 | SaleCommon Stock | 3,000 | $56.46 | $169,379.70 |
DisclosureSEC source: 0000900075-16-000138 · wf-form4_148244566941428.xml · nonDerivative · entry 1 BHATIA VIKRANT · CIK 0001628240 · EVP Strategic Initiatives 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,181 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.